Skip to main content
. Author manuscript; available in PMC: 2011 Jul 8.
Published in final edited form as: Clin Chem. 2009 Aug 13;55(10):1861–1868. doi: 10.1373/clinchem.2009.125898

Table 2.

Actual dosing schedules described in case reports.

Dosing
Case 1. Guided by INR monitoring only (Fig. 4A)
 Day 1 0 mg
 Day 2 5 mg
 Day 3 7.5 mg
 Days 4–9 5 mg
 Days 10–16 5 mg
 Days 17–22 Alternating: 5 and 2.5 mg
 Days 23–48 3 mg
 Days 49–90 Alternating: 3, 3, and 5 mg
Case 2. Guided by INR monitoring and genotype (Fig. 4B)
 Day 1 5 mg
 Days 2–3 6 mg
 Days 4–8 7 mg
 Days 9–22 7 mg